摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Phenyl-3-[2-(1-phenylethylamino)pyrimidin-4-yl]imidazo[1,2-a]pyrimidin-7-amine

中文名称
——
中文别名
——
英文名称
2-Phenyl-3-[2-(1-phenylethylamino)pyrimidin-4-yl]imidazo[1,2-a]pyrimidin-7-amine
英文别名
——
2-Phenyl-3-[2-(1-phenylethylamino)pyrimidin-4-yl]imidazo[1,2-a]pyrimidin-7-amine化学式
CAS
——
化学式
C24H21N7
mdl
——
分子量
407.5
InChiKey
KFEQXUZWOONGQK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.6
  • 重原子数:
    31
  • 可旋转键数:
    5
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.08
  • 拓扑面积:
    94
  • 氢给体数:
    2
  • 氢受体数:
    6

文献信息

  • SUBSTITUTED 2-ARYL-3-(HETEROARYL)-IMIDAZO[1,2-ALPHA]PYRIMIDINES, AND RELATED PHARMACEUTICAL COMPOSITIONS AND METHODS
    申请人:Ortho-McNeil Pharmaceutical, Inc.
    公开号:EP1140939A1
    公开(公告)日:2001-10-10
  • EGFR KINASE INHIBITOR COMBINATIONS FOR THE TREATMENT OF RESPIRATORY AND GASTROINTESTINAL DISORDERS
    申请人:Boehringer Ingelheim International GmbH
    公开号:EP2086641A2
    公开(公告)日:2009-08-12
  • PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF RESPIRATORY AND GASTROINTESTINAL DISORDERS
    申请人:Jung Birgit
    公开号:US20100099651A1
    公开(公告)日:2010-04-22
    The present invention relates to novel pharmaceutical compositions comprising at least one EGFR kinase inhibitor and at least one additional active compound selected from beta-2 mimetics, steroids, PDE-IV inhibitors, p38 MAP kinase inhibitors, NK 1 antagonists, anticholinergics and endothelin antagonists, processes for preparing the compositions and the use thereof as medicament in the treatment of respiratory or gastrointestinal complaints, as well as inflammatory diseases of the joints, the skin or the eyes.
  • US6610697B1
    申请人:——
    公开号:US6610697B1
    公开(公告)日:2003-08-26
  • [EN] SUBSTITUTED 2-ARYL-3-(HETEROARYL)-IMIDAZO[1,2-a]PYRIMIDINES, AND RELATED PHARMACEUTICAL COMPOSITIONS AND METHODS<br/>[FR] 2-ARYL-3-(HETEROARYL)-IMIDAZO[1,2-a]PYRIMIDINES SUBSTITUEES, ET COMPOSITIONS PHARMACEUTIQUES ET PROCEDES ASSOCIES
    申请人:ORTHO MCNEIL PHARM INC
    公开号:WO2001034605A1
    公开(公告)日:2001-05-17
    This invention relates to a series of imidazopyrimidines of Formula (I), and pharmaceutical compositions containing them. The compounds of the invention inhibit the production of a number of inflammatory cytokines and are useful in the treatment and prevention of diseases associated with the overproduction thereof.
查看更多